Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Softgel Capsules Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Softgel Capsules Market Analysis Tools
3.4.1. Industry Analysis – Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Softgel Capsules: Type Estimates & Trend Analysis
4.1. Softgel Capsules Market: Type Key Takeaways
4.2. Softgel Capsules Market: Type Movement & Market Share Analysis, 2022 & 2030
4.3. Gelatin-Based/Animal-Based
4.3.1. Gelatin-based/Animal-based market estimates and forecasts, 2018 to 2030, (USD Million)
4.4. Non-Animal-Based
4.4.1. Non-Animal-Based market estimates and forecasts, 2018 to 2030, (USD Million)
Chapter 5. Softgel Capsules: Application Estimates & Trend Analysis
5.1. Softgel Capsules Market: ApplicationKey Takeaways
5.2. Softgel Capsules Market: Application Movement & Market Share Analysis, 2022 & 2030
5.3. Antacid and Anti-Flatulent Preparation
5.3.1. Antacid and anti-flatulent preparation market estimates and forecasts, 2018 to 2030, (USD Million)
5.4. Anti-Anemic Preparations
5.4.1. Anti-anemic preparations market estimates and forecasts, 2018 to 2030, (USD Million)
5.5. Anti-Inflammatory Drugs
5.5.1. Anti-inflammatory drugs market estimates and forecasts, 2018 to 2030, (USD Million)
5.6. Antibiotic and Antibacterial Drugs
5.6.1. Antibiotic and antibacterial drugs market estimates and forecasts, 2018 to 2030, (USD Million)
5.7. Cough and Cold Preparations
5.7.1. Cough and cold preparations market estimates and forecasts, 2018 to 2030, (USD Million)
5.8. Health Supplement
5.8.1. Health supplement market estimates and forecasts, 2018 to 2030, (USD Million)
5.9. Vitamin and Dietary Supplement
5.9.1. Vitamin and dietary supplement market estimates and forecasts, 2018 to 2030, (USD Million)
5.10. Pregnancy
5.10.1. Pregnancy market estimates and forecasts, 2018 to 2030, (USD Million)
Chapter 6. Softgel Capsules: End Use Estimates & Trend Analysis
6.1. Softgel Capsules Market: End-use Key Takeaways
6.2. Softgel Capsules Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Pharmaceutical Companies
6.3.1. Pharmaceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
6.4. Nutraceutical Companies
6.4.1. Nutraceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
6.5. Cosmeceutical Companies
6.5.1. Cosmeceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
6.6. Contract Manufacturing Organizations
6.6.1. Contract manufacturing organizations market estimates and forecasts, 2018 to 2030, (USD Million)
Chapter 7. Softgel Capsules Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Softgel Capsules Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Fuji Capsule
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Sirio Pharma Co., Ltd.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. CAPTEK Softgel International Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Thermo Fisher Scientific Inc.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. EyePoint Pharmaceuticals, Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Catalent, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. EuroCaps
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Aenova Group
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Lonza Capsules & Health Ingredients
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. ProCaps Laboratories, LLC
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Soft Gel Technologies, Inc.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives